Kathryn Edwards, MD, the Sarah H. Sell and Cornelius Vanderbilt Professor of Medicine, is one of the nation’s top vaccine experts. A member of the National Academy of Medicine, she focuses on the evaluation of vaccines for the prevention of infectious diseases in adults and children. Q: Are there any vaccines that can prevent cancer? […]
Singer celebrates last treatment with famous friends Singer Anita Cochran had famous friends in the room when she celebrated her last cancer treatment, but the person with her who mattered the most was her 89-year-old father. A fellow cancer survivor, he stood beside her inside Vanderbilt-Ingram Cancer Center (VICC) at Cool Springs and helped her […]
Advanced imaging tools reveal architecture of cell division machinery For years, Kathleen Gould, PhD, and her colleagues have drawn models of the contractile ring — the molecular apparatus that physically divides cells — and its parts. They used genetic studies to probe how the protein parts fit together, but their models involved some educated guesses. […]
VICC committed to increasing HPV vaccinations Vanderbilt-Ingram Cancer Center (VICC) experts and the Prevent Cancer Foundation urged the public to “think about the link” between viruses and cancer during a July seminar. The event, held in conjunction with the Tennessee Cancer Consortium’s annual conference, was one of several initiatives by VICC during 2017 to raise […]
21st Century Cures Act supports cancer research Lawmakers on both sides of the political aisle, along with patients, physicians and scientists agree on one urgent priority—the need to accelerate the pace of scientific discovery to address a range of serious and costly illnesses, from cancer to Alzheimer’s disease. In a spirit of harmony and far-reaching […]
Hiebert appointed to national cancer board Scott Hiebert, Ph.D., professor of Biochemistry and associate professor of Medicine, has been appointed to the National Cancer Advisory Board (NCAB). The NCAB consists of 18 members appointed by the President to advise the director of the National Cancer Institute (NCI), a division of the National Institutes of Health […]
A possible targeted therapy emerges for triple-negative breast cancer A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies. The new study led by […]
Kachnic is new chair of Radiation Oncology Lisa Kachnic, M.D., is now professor and chair of the Vanderbilt Department of Radiation Oncology. She came to Vanderbilt from the Boston University School of Medicine, where she served as professor and chair of Radiation Oncology and associate director of Multidisciplinary Cancer Research. She was also the chief of […]
Program focuses on heart health of cancer patients The Vanderbilt Cardio-Oncology program has fostered a special collaborative relationship combining the expertise of cardiologists and oncologists to understand the effects of cancer therapy on the heart. This type of collaboration is now helping to define the cardiovascular health of more than 14 million cancer survivors in […]
T.J. Martell Foundation lauds Hiebert’s research Scott Hiebert, Ph.D., associate director of Basic Research at Vanderbilt-Ingram Cancer Center, was celebrated for his contributions to cancer research during the 6th Annual Nashville Honors Gala benefiting the T.J. Martell Foundation. This year’s event at Nashville’s Omni Hotel honored five Nashville community leaders who work diligently to make […]
